These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36373213)

  • 21. Pharmaceutical agents for the treatment of Chagas disease: patenting trends in the 2016-2021 period.
    Flores-Quiroz VI; Zumaquero-Ríos L; Perez-Santos M
    Pharm Pat Anal; 2022 May; 11(3):97-110. PubMed ID: 35861035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Approaches for the Treatment of Chagas Disease.
    Pandey RP; Nascimento MS; Moore CE; Raj VS; Kalil J; Cunha-Neto E
    Curr Drug Targets; 2021; 22(7):835-841. PubMed ID: 33238855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and Biological in vitro and in vivo Evaluation of 2-(5-Nitroindazol-1-yl)ethylamines and Related Compounds as Potential Therapeutic Alternatives for Chagas Disease.
    Martín-Escolano R; Aguilera-Venegas B; Marín C; Martín-Montes Á; Martín-Escolano J; Medina-Carmona E; Arán VJ; Sánchez-Moreno M
    ChemMedChem; 2018 Oct; 13(19):2104-2118. PubMed ID: 30098232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaches to advance drug discovery for neglected tropical diseases.
    Ferreira LLG; de Moraes J; Andricopulo AD
    Drug Discov Today; 2022 Aug; 27(8):2278-2287. PubMed ID: 35398562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From Medicinal Chemistry to Human Health: Current Approaches to Drug Discovery for Cancer and Neglected Tropical Diseases.
    Ferreira LG; Oliva G; Andricopulo AD
    An Acad Bras Cienc; 2018; 90(1 Suppl 1):645-661. PubMed ID: 29451603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential new clinical therapies for Chagas disease.
    Bustamante JM; Tarleton RL
    Expert Rev Clin Pharmacol; 2014 May; 7(3):317-25. PubMed ID: 24716790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience.
    Johnston KL; Ford L; Taylor MJ
    J Biomol Screen; 2014 Mar; 19(3):335-43. PubMed ID: 24241712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yeast as a potential vehicle for neglected tropical disease drug discovery.
    Denny PW; Steel PG
    J Biomol Screen; 2015 Jan; 20(1):56-63. PubMed ID: 25121554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in Chagas disease drug development: 2009-2010.
    Buckner FS; Navabi N
    Curr Opin Infect Dis; 2010 Dec; 23(6):609-16. PubMed ID: 20885320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent approaches in nanocarrier-based therapies for neglected tropical diseases.
    Mengarda AC; Iles B; Longo JPF; de Moraes J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1852. PubMed ID: 36161523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chagas: a neglected tropical disease.
    Lindo JF
    West Indian Med J; 2012 Sep; 61(6):557-8. PubMed ID: 23441346
    [No Abstract]   [Full Text] [Related]  

  • 32. [Introduction of "Access to Health" Initiatives for Neglected Tropical Diseases (NTDs)～R&D of NTD Medicines～].
    Domoto F; Kojima H; Tasaki H
    Yakugaku Zasshi; 2022; 142(7):715-720. PubMed ID: 35781499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug discovery and development for neglected diseases: the DNDi model.
    Chatelain E; Ioset JR
    Drug Des Devel Ther; 2011 Mar; 5():175-81. PubMed ID: 21552487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting cysteine proteases in trypanosomatid disease drug discovery.
    Ferreira LG; Andricopulo AD
    Pharmacol Ther; 2017 Dec; 180():49-61. PubMed ID: 28579388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leishmaniasis and Chagas Disease - Neglected Tropical Diseases: Treatment Updates.
    Sangenito LS; da Silva Santos V; d'Avila-Levy CM; Branquinha MH; Souza Dos Santos AL; de Oliveira SSC
    Curr Top Med Chem; 2019; 19(3):174-177. PubMed ID: 30950334
    [No Abstract]   [Full Text] [Related]  

  • 36. Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases.
    Dichiara M; Marrazzo A; Prezzavento O; Collina S; Rescifina A; Amata E
    ChemMedChem; 2017 Aug; 12(16):1235-1253. PubMed ID: 28590590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current and Future Chemotherapy for Chagas Disease.
    Gaspar L; Moraes CB; Freitas-Junior LH; Ferrari S; Costantino L; Costi MP; Coron RP; Smith TK; Siqueira-Neto JL; McKerrow JH; Cordeiro-da-Silva A
    Curr Med Chem; 2015; 22(37):4293-312. PubMed ID: 26477622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological factors that impinge on Chagas disease drug development.
    Francisco AF; Jayawardhana S; Lewis MD; Taylor MC; Kelly JM
    Parasitology; 2017 Dec; 144(14):1871-1880. PubMed ID: 28831944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chagas Disease: Current View of an Ancient and Global Chemotherapy Challenge.
    Martín-Escolano J; Medina-Carmona E; Martín-Escolano R
    ACS Infect Dis; 2020 Nov; 6(11):2830-2843. PubMed ID: 33034192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lead identification to clinical candidate selection: drugs for Chagas disease.
    Neitz RJ; Chen S; Supek F; Yeh V; Kellar D; Gut J; Bryant C; Gallardo-Godoy A; Molteni V; Roach SL; Khare S; Stinson M; Chatterjee AK; Robertson S; Renslo AR; Arkin M; Glynne R; McKerrow J; Siqueira-Neto JL
    J Biomol Screen; 2015 Jan; 20(1):101-11. PubMed ID: 25281737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.